NDC Compounded Drug 73702-135-80 Ropivacaine Hydrochloride
Injection Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Ropivacaine Hydrochloride
NDC crossover of Ropivacaine Hcl with NDC 73702-135 a human compounded drug with other similar products matching the same substance name (Ropivacaine Hydrochloride) and the same administration route (intravenous) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
71266-9130-1 | Ropivacaine | Ropivacaine | 20 mL in 1 SYRINGE, PLASTIC | Injection | Infiltration | Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories |
73177-109-13 | Ropivacaine | Ropivacaine | 545 mL in 1 CONTAINER | Injection | Infiltration | Staq Pharma Inc |
73177-109-14 | Ropivacaine | Ropivacaine | 745 mL in 1 CONTAINER | Injection | Infiltration | Staq Pharma Inc |
Frequently Asked Questions
What is the NDC number assigned to Ropivacaine?
Ropivacaine was assigned by its manufacturer with NDC product code 73702-135. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Ropivacaine?
The NDC package code 73702-135-80 was assigned to a 275 mL in 1 KIT of ropivacaine hydrochloride administered intravenous via injection.
Who manufactures this product?
Ropivacaine is manufactured by an outsourced facility and labeled by Wells Pharma Of Houston. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 3 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories and STAQ Pharma Inc with NDC product codes 71266-9130-1, 73177-109-13 and 73177-109-14.